Proteogenomic analysis unveils the HLA Class I presented immunopeptidome in melanoma and EGFR mutant lung adenocarcinoma
Y. A. Qi, T. K. Maity, C. M. Cultraro, V. Misra, X. Zhang, C. Ade, S. Gao, D. Milewski, K. D. Nguyen, M. H. Ebrahimabadi, K.-i. Hanada, J. Khan, C. Sahinalp, J. C. Yang, U. Guha
The paper identifies HLA Class I-presented peptides in melanoma and EGFR mutant lung adenocarcinoma using proteogenomic analysis, revealing neopeptides and post-translationally modified peptides for potential immunotherapy.
bioRxiv · Aug 4, 2020Immunology